Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Probes Acquires Interfacial Dynamics

By HospiMedica staff writers
Posted on 30 Apr 2003
In a move to expand its bead-based assay systems, Molecular Probes, Inc. More...
(Eugene, OR, USA) has acquired Interfacial Dynamics Corp. (IDC, Portland, OR, USA). Financial terms were not disclosed.

IDC will become a wholly owned subsidiary of Molecular Probes. IDC was a pioneer in the production of surfactant-free, high-quality, reproducible latex microspheres. The acquisition gives Molecular Probes the ability to design and manufacture these latex microspheres for its own products and to offer a full line of microspheres to customers. Molecular Probes is a leading global provider of fluorescence-based detection assays.

"Adding IDC's outstanding capabilities in microsphere development and manufacturing to our expertise in fluorescence and conjugation, along with our relationships with major reagent, diagnostic, and instrument companies, gives us numerous opportunities to develop new bead-based assays and particle-based detection systems for a wide variety of uses,” said Anthony Martin, Ph.D., president and CEO of Molecular Probes.





Related Links:
Molecular Probes
Interfacial Dynamics

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.